Andrea Carfi, Ph.D.

VP & Head of Research, Infectious Disease, Moderna Inc.

Philip R. Dormitzer, M.D., Ph.D.

Vice President and Chief Scientific Officer, Viral Vaccines, Pfizer

Kathleen Maletic Neuzil, MD, MPH, FIDSA

Director, Center for Vaccine Development and Global Health, UMSOM

Julie A. Ake, M.D.

Director, US Military HIV Research Program

Jerald C. Sadoff, M.D.

Senior Advisor Vaccine Development, Janssen Vaccines & Prevention B.V.

Derek T. O' Hagan, BPharm, MRPharmS, Ph.D.

Senior Advisor Vaccines R&D, GSK

Pei-Yong Shi, Ph.D.

John Sealy Distinguished Chair in Innovations in Molecular Biology UTMB at Galveston

Jacqueline M. Miller, M.D., FAAP

Sr. VP & Therapeutic Area Head, Infectious Disease, Moderna Inc

Adrian McDermott, Ph.D.

Chief, Vaccine Immunology Program, NIAID, NIH

Dan H. Barouch, M.D., Ph.D.

Director, Center for Virology and Vaccine Research, BIDMC

Kate Broderick, Ph.D.

Senior Vice President, R&D, INOVIO

Doran L. Fink, M.D., Ph.D.

Deputy Director - Clinical, Division of Vaccines and Related Products Applications FDA/CBER

Trudy Morrison, Ph.D.

Professor, University of Massachusetts Medical School

Alexandre Le Vert, M.S.

Executive Chairman and Cofounder OSIVAX

Alexander Bukreyev, Ph.D.

Professor, University of Texas Medical Branch at Galveston

David B. Weiner, Ph.D.

Director, The Wistar Institute

Marcus A. Horwitz, M.D.

Professor, UCLA School of Medicine

Yingxia Wen, Ph.D.

Sr. Director, Head of Discovery Research at Seqirus

Michael G. Hanna Jr., Ph.D.

Director, Chairman Emeritus, Vaccinogen Inc.

George N. Pavlakis, M.D., Ph.D.

Chief, Human Retrovirus Section, Vaccine Branch, CCR, NCI

Vincent K. Tuohy, Ph.D.

Professor, Lerner College of Medicine, Cleveland Clinic

Sylvie Alonso, Ph.D.

Deputy Director, Life Sciences Institute, NUS, Singapore

Nathaniel R. Landau, Ph.D.

Professor, Department of Microbiology, NYU Grossman School of Medicine

Geoffrey Lynn, Ph.D.

CEO and Co-founder, Avidea Technologies, Baltimore

Matthew Frieman, Ph.D.

Assoc. Prof., Department of Microbiology and Immunology, UMSOM

David Martinez, Ph.D.

Hanna H. Gray Fellow of Howard Hughes Medical Institute, UNC-Chapel Hill

M. Javad Aman, Ph.D.

President and CSO, Integrated BioTherapeutics

Catarina Hioe, Ph.D.

Professor, Icahn School of Medicine at Mount Sinai

Jennifer Rainho-Tomko, Ph.D.

Scientist II, Sanofi Pasteur

Yongjun Sui, Ph.D.

Associate Scientist, Vaccine Branch, CCR, NCI

Oreola Donini, Ph.D.

Chief Scientific Officer, Soligenix, Inc.

Kaitlyn M. Morabito, Ph.D., M.S.

Program Officer, Flaviviruses, Virology Branch, Division of Microbiology and Infectious Diseases, NIAID, NIH

Marie-Claire Gauduin, Ph.D.

Associate Professor, Disease Intervention and Prevention, Texas Biomedical Research Institute

Janet Lathey, Ph.D.

Program Officer, Office of Biodefense, Research Resources, and Translational Research, DMID/NIAID/NIH

Tracy Ruckwardt Ph.D.

Staff Scientist and Unit Head, Vaccine Immunobiology Unit, NIAID, NIH

Masaru Kanekiyo D.V.M., Ph.D.

Earl Stadtman Investigator, Chief, Molecular Immunoengineering Section, VRC, NIAID/NIH

Eric Andrew Appel Ph.D.

Assistant Professor, Department of Materials Science & Engineering, Stanford University

Michael A Schotsaert Ph.D.

Assistant Professor, Microbiology, Icahn School of Medicine at Mount Sinai

Scott Burkholz M.S.

Bioinformatics Data Scientist, Flow Pharma

Heather Friberg Ph.D.

Chief, Department of Virus-Host Interactions, Viral Diseases Branch, WRAIR

Purnima Dubey Ph.D.

Associate Professor Department of Microbiology, The Ohio State University

Rama Rao Amara Ph.D.

Associate Director, Vaccine Development, Emory Vaccine Center

Benjamin Doranz Ph.D.

President, Integral Molecular

Andrew Lees Ph.D.

CEO/CSO, Fina Biosolutions

M. Sohaib Khan

University of Pittsburgh Graduate School of Public Health